| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MINIM, INC. | Director | Common Stock | 159K | $241K | $1.51 | Sep 26, 2024 | By: NLT Management and Asset Holding Company LTD |
| OPGEN INC | Director | Common Stock | 100K | $85K | $0.85 | Apr 11, 2024 | Direct |
| TITAN PHARMACEUTICALS INC | Director | Common Stock | 66.3K | $81.5K | $1.23 | Oct 25, 2023 | Direct |
| MINIM, INC. | Director | Common Stock | 25K | $37.8K | $1.51 | Sep 26, 2024 | Direct |
| Cyclacel Pharmaceuticals, Inc. | Director | Common Stock | 0 | $0 | $3.32 | Jan 5, 2025 | Direct |
| Cyclacel Pharmaceuticals, Inc. | Director | Non-Qualified Stock Option (Right to Buy) | 700K | Feb 26, 2025 | Direct | ||
| TITAN PHARMACEUTICALS INC | Director | Option to Purchase Common Stock | 100K | Jun 29, 2023 | Direct | ||
| LQR House Inc. | Director | Common Stock | 0 | Oct 16, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CYCC | Cyclacel Pharmaceuticals, Inc. | Feb 26, 2025 | 1 | $0 | 4 | Feb 28, 2025 | Director |
| CYCC | Cyclacel Pharmaceuticals, Inc. | Jan 5, 2025 | 0 | $0 | 3 | Jan 8, 2025 | Director |
| LQR | LQR House Inc. | Oct 16, 2024 | 0 | $0 | 3 | Oct 23, 2024 | Director |
| MINM | MINIM, INC. | Sep 26, 2024 | 1 | $0 | 4 | Oct 1, 2024 | Director |
| OPGN | OPGEN INC | Apr 11, 2024 | 1 | $0 | 4 | Apr 15, 2024 | Director |
| OPGN | OPGEN INC | Mar 25, 2024 | 0 | $0 | 3 | Apr 3, 2024 | Director |
| MINM | MINIM, INC. | Jan 22, 2024 | 1 | $0 | 4 | Jan 24, 2024 | Director |
| MINM | MINIM, INC. | Dec 29, 2023 | 0 | $0 | 3 | Jan 4, 2024 | Director |
| TTNP | TITAN PHARMACEUTICALS INC | Oct 25, 2023 | 1 | $0 | 4 | Oct 26, 2023 | Director |
| TTNP | TITAN PHARMACEUTICALS INC | Jul 26, 2023 | 3 | $0 | 4 | Jul 31, 2023 | Director |
| TTNP | TITAN PHARMACEUTICALS INC | Aug 15, 2022 | 0 | $0 | 3 | Aug 30, 2022 | Director |